Previous studies find that HCP5 is regarded as an oncogene via accelerating cancer cell growth, metastasis, and drug resistance in renal cell carcinoma, gastric cancer, and colorectal cancer (10–12). The gene discussed is HCP5; the disease is gastric cancer.